Muhammad Khattab1, Ahmed A Al-Karmalawy2. 1. Department of Chemistry of Natural & Microbial Products, Division of Pharmaceutical & Drug Industries, National Research Centre, Cairo, 12622, Egypt. 2. Department of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta, 34518, Egypt.
Abstract
Background: Although some benzimidazole-based anthelmintic drugs are found to possess anticancer activity, their modes of binding interactions have not been reported. Methodology: In this study, we aimed to investigate the binding interactions and electronic configurations of nine benzimidazole-based anthelmintics against one of the well-known cancer targets (tubulin protein). Results: Binding affinities of docked benzimidazole drugs into colchicine-binding site were calculated where flubendazole > oxfendazole > nocodazole > mebendazole. Flubendazole was found to bind more efficiently with tubulin protein than other drugs. Quantum mechanics studies revealed that the electron density of HOMO of flubendazole and mebendazole together with their molecular electrostatic potential map are closely similar to that of nocodazole. Conclusion: Our study has ramifications for considering repurposing of flubendazole as a promising anticancer candidate.
Background: Although some benzimidazole-based anthelmintic drugs are found to possess anticancer activity, their modes of binding interactions have not been reported. Methodology: In this study, we aimed to investigate the binding interactions and electronic configurations of nine benzimidazole-based anthelmintics against one of the well-known cancer targets (tubulin protein). Results: Binding affinities of docked benzimidazole drugs into colchicine-binding site were calculated where flubendazole > oxfendazole > nocodazole > mebendazole. Flubendazole was found to bind more efficiently with tubulin protein than other drugs. Quantum mechanics studies revealed that the electron density of HOMO of flubendazole and mebendazole together with their molecular electrostatic potential map are closely similar to that of nocodazole. Conclusion: Our study has ramifications for considering repurposing of flubendazole as a promising anticancer candidate.
Authors: Ayman Abo Elmaaty; Khaled M Darwish; Amani Chrouda; Amira A Boseila; Mohamed A Tantawy; Sameh S Elhady; Afzal B Shaik; Muhamad Mustafa; Ahmed A Al-Karmalawy Journal: ACS Omega Date: 2021-12-22
Authors: Rogy R Ezz Eldin; Marwa A Saleh; Mohammad Hayal Alotaibi; Reem K Alsuair; Yahya A Alzahrani; Feras A Alshehri; Amany F Mohamed; Shaimaa M Hafez; Azza Ali Althoqapy; Seham K Khirala; Mona M Amin; Yousuf A F; Azza H AbdElwahab; Mohamed S Alesawy; Ayman Abo Elmaaty; Ahmed A Al-Karmalawy Journal: J Enzyme Inhib Med Chem Date: 2022-12 Impact factor: 5.756
Authors: Nada A Ashour; Ayman Abo Elmaaty; Amany A Sarhan; Eslam B Elkaeed; Ahmed M Moussa; Ibrahim Ali Erfan; Ahmed A Al-Karmalawy Journal: Drug Des Devel Ther Date: 2022-03-15 Impact factor: 4.162
Authors: Mohamed A Salem; Nora M Aborehab; Ahmed A Al-Karmalawy; Alisdair R Fernie; Saleh Alseekh; Shahira M Ezzat Journal: Antioxidants (Basel) Date: 2022-02-25